Search Results 3951-3960 of 25114 for oral

  1. Waldenstrom Macroglobulinemia Clinical Trials

    The purpose of this study is to evaluate oral LOXO-305 in patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) or Non-Hodgkin ...

  2. A study to assess the effectiveness and safety of pacritinib in patients with VEXAS syndrome (PAXIS) - Mayo Clinic

    Oral JAK inhibitors: 14 days; Anti-IL-1 agents except for canakinumab: 14 days; Any other non-GC anti-inflammatory therapy (e.g., mycophenolate, azathioprine ...

  3. Phase 1 Study to Evaluate MEDI4736 in Subjects With Myelodysplastic Syndrome - Mayo Clinic

    ... oral hormonal contraceptive pills where inhibition of ovulation is not the primary mode of action [excluding Cerazette®/desogestrel which is considered ...

  4. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

  5. Mayo Clinic Minute: Do you have hypothyroidism?

    Bernet. Often, treatment is simply taking daily oral thyroid medication to return hormone levels to a typical range. And treatment likely will be lifelong.

  6. Faculty Misconduct Policy

    Allegation: Any written or oral statement or other indication of possible faculty misconduct made to education administration or leadership. Faculty ...

  7. A Study to Evaluate Dabrafenib and Trametinib With or Without Hydroxychloroquine in Advanced Melanoma - Mayo Clinic

    Patient must have discontinued any oral targeted therapy at least 2 weeks prior to randomization. Patients must not receive any other investigational ...

  8. Arsenic trioxide (intravenous route) - Mayo Clinic

    Arsenic trioxide injection is used together with another medicine (eg, tretinoin) to treat newly-diagnosed low-risk acute promyelocytic leukemia (APL), a type ...

  9. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

  10. Update on the management of ANCA-associated vasculitis - Mayo Clinic

    ... oral azathioprine for maintenance of remission. This trial also showed rituximab to be cost-effective because higher drug costs were offset by increased ...